Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir

The UN health agency on Thursday recommended the use of a new long-acting “safe and highly effective” prevention option for people at “substantial risk” of HIV infection, known as cabotegravir (CAB-LA).

Read the full story, “Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir”, on globalissues.org →

find more fun & mates at SoShow now !